Browsing: cannabis

The clinical evidence is real. The valuations are not. Compass Pathways: $560 million market cap, zero revenue. MindMed: up to $2 billion, zero revenue. Even Ozempic…

The US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) to VER-01, the flagship full-spectrum cannabis drug from Munich-based Vertanical, putting it in…

A study by students at the Birmingham Heersink School of Medicine has found that cannabis users show no significant difference in overall physical activity levels compared…

Kentucky Gov. Andy Beshear (D) signed an executive order on Tuesday instructing the Office of Medical Cannabis to dispel doubts about the state’s medical cannabis qualifying…

When legal cannabis markets first opened, the industry celebrated availability. Getting product to consumers safely and legally was the mission, and for a long time, that…

In a new multi-clinic survey, the majority of UK patients being treated with medical cannabis for anxiety, depression, and PTSD report improvements in their symptoms.  The…

Minnesota Gov. Tim Walz (D) last week signed into law legislation streamlining the state’s medical and adult-use cannabis supply chains.  The law eliminates the state’s current combination medical and adult-use cannabis license,…

Children exposed to cannabis in the womb do not show signs of impaired cognitive or language development by age three, according to new research that challenges…

For the first time ever, flower is no longer king of the cannabis industry, with a new report revealing that in 2025 pre-rolls became the first…

Nearly 90% of patients with arthritis and musculoskeletal (MSK) joint pain regard cannabis as an effective and safe pain treatment, according to a new Canadian study.The…